This New Fund Offers Targeted Exposure To Junior Biotech Disruptors
There’s a new ETF on the scene with a focus on small-cap biotech companies, offering investors exposure to junior disruptors in the biotech space. For…
Zenect Wealth
COVID & Psychedelics: 3 Biotech Penny Stocks To Watch In August
“With coronavirus cases climbing in the U.S., this is likely going to be a clear focus for quite some time,” declares the author of today’s…
“The Era Of Biotechs”
“The paralyzing viral outbreak that has swept the planet, costing trillions in output and gumming up the wheels of the global economy has also created…
4 “Hidden Tech Gems” In The Much Appreciated Sector
“Investors have rewarded tech stocks richly during, and prior to the pandemic. Yet, there are gems that remain hidden within the sector,” advises the author…
Profit From The Coming Battery Boom With This Lithium Leader
If your phone or car uses a lithium-ion battery, the company highlighted in today’s article likely manufactured the lithium chemical used in that battery –…
Harnessing The Power Of “Earnings Whispers” – And Other Strategies To Profit This (Unusual) Earnings Season
In this unusual earnings season that is getting underway, the author of today’s article observes that “Any stocks unfortunate enough to hiccup…will be severely punished.…
3 “Strong Buy” Penny Stocks With Massive Upside Potential For Risk-Tolerant Investors
The market strategist cited in today’s article believes that the current stock market situation will get “resolved to the upside” – and for risk-tolerant investors…
U.S. Traders May Be Accidentally Buying This Biotech Stock – But It May Be Worth Owning Anyways!
Shares of the biotech highlighted in today’s article have soared this year, but is this performance due to factors such as the COVID-19 drug the…
What To Know About These Top Biotech Stocks To Watch
“July is a critical month for several leading biotech companies, and there’s a lot that investors need to know if they want to make a…
Options For An Uncertain Earnings Season
With second-quarter earnings season getting underway against what the author of today’s article acknowledges is “one of the most uncertain backdrops ever”, he advises that…